-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Mereo BioPharma Group plc quarterly/annual General and Administrative Expense history and growth rate from Q1 2023 to Q3 2024.
- Mereo BioPharma Group plc General and Administrative Expense for the quarter ending September 30, 2024 was $6.2M, a 8.67% increase year-over-year.
- Mereo BioPharma Group plc General and Administrative Expense for the twelve months ending September 30, 2024 was $23.6M.
- Mereo BioPharma Group plc annual General and Administrative Expense for 2023 was $18.4M, a 29.4% decline from 2022.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)